| [1] |
Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030[J]. Diabetes Res Clin Pract, 2011, 94(3):311-321.
|
| [2] |
Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035[J]. Diabetes Res Clin Pract, 2014, 103(2):137-149.
|
| [3] |
Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes[J]. Lancet, 2012, 379(9833):2300-2311.
|
| [4] |
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis[J]. Am J Med, 2009, 122(3):248-256.
|
| [5] |
Hall TC, Pellen MG, Sedman PC, et al. Preoperative factors predi cting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity[J]. Obes Surg, 2010, 20(9):1245-1250.
|
| [6] |
Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic tesponse to gastric bypass surgery in patients with type 2 diabetes[J].Diabetes Care, 2013, 36(1):20-26.
|
| [7] |
张晓娟, 杜涓, 杜潇等. 腹腔镜下胃转流术治疗肥胖型2 型糖尿病的疗效分析[J]. 中国普外基础与临床杂志, 2012, 19(12):1272-1277.
|
| [8] |
Hedberg J, Sundström J, Sundbom M. Duodenal switch versus Rouxen-Y gastric bypass for morbid obesity: systematic review and metaanalysis of weight results, diabetes resolution and early complications in single-centre comparisons[J]. Obes Rev, 2014, 15(7):555-563.
|
| [9] |
Dogan K, Betzel B, Homan J, et al. Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients[J]. Obes Surg, 2014,24(11):1835-1842.
|
| [10] |
Buchwald H, Buchwald JN, McGlennon TW. Systematic review and meta-analysis of medium-term outcomes after banded Roux-en-Y gastric bypass[J]. Obes Surg, 2014, 24(9):1536-1551.
|